6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents
Version 2 2017-09-13, 13:50
Version 1 2017-09-13, 13:43
Posted on 2017-09-13 - 13:50
Structurally unique 6,7-seco-ent-kaurenes, which are widely distributed in the genus Isodon, have attracted considerable attention because of
their antitumor activities. Previously, a convenient conversion of
commercially available oridonin (1) to 6,7-seco-ent-kaurenes was developed. Herein, several novel spiro-lactone-type ent-kaurene derivatives bearing various substituents at
the C-1 and C-14 positions were further designed and synthesized from
the natural product oridonin. Moreover, a number of seven-membered
C-ring-expanded 6,7-seco-ent-kaurenes were also identified
for the first time. It was observed that most of the spiro-lactone-type ent-kaurenes tested markedly inhibited the proliferation
of cancer cells, with an IC50 value as low as 0.55 μM.
An investigation on its mechanism of action showed that the representative
compound 7b affected the cell cycle and induced apoptosis
at a low micromolar level in MCF-7 human breast cancer cells. Furthermore,
compound 7b inhibited liver tumor growth in an in vivo
mouse model and exhibited no observable toxic effects. Collectively,
the results warrant further preclinical investigations of these spiro-lactone-type ent-kaurenes as potential novel anticancer agents.
CITE THIS COLLECTION
DataCite
3 Biotech
3D Printing in Medicine
3D Research
3D-Printed Materials and Systems
4OR
AAPG Bulletin
AAPS Open
AAPS PharmSciTech
Abhandlungen aus dem Mathematischen Seminar der Universität Hamburg
ABI Technik (German)
Academic Medicine
Academic Pediatrics
Academic Psychiatry
Academic Questions
Academy of Management Discoveries
Academy of Management Journal
Academy of Management Learning and Education
Academy of Management Perspectives
Academy of Management Proceedings
Academy of Management Review
Xu, Shengtao; Yao, Hong; Hu, Mei; Li, Dahong; Zhu, Zheying; Xie, Weijia; et al. (2017). 6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents. ACS Publications. Collection. https://doi.org/10.1021/acs.jnatprod.7b00057
or
Select your citation style and then place your mouse over the citation text to select it.
SHARE
Usage metrics
Read the peer-reviewed publication
AUTHORS (10)
SX
Shengtao Xu
HY
Hong Yao
MH
Mei Hu
DL
Dahong Li
ZZ
Zheying Zhu
WX
Weijia Xie
HY
Hequan Yao
LW
Liang Wu
ZC
Zhe-Sheng Chen
JX
Jinyi Xu